DO VITAMIN D DEFICIENCY AND HEPATITIS C VIRUS INFECTION PLAY A ROLE IN OXIDATIVE STRESS IN PATIENTS ON MAINTENANCE HEMODIALYSIS?

References

• Locatelli F, Canaud B, Eckardt KU, et al. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. NDT. 2003;18(7):1272–1280.
   PubMed Web of Science ®Google Scholar
• Liakopoulos V, Roumeliotis S, Gorny X, et al. Oxidative Stress in Hemodialysis Patients: a Review of the Literature. Oxid Med Cell Longev. 2017;2017:e3081856.
   PubMed Web of Science ®Google Scholar
• Berridge MJ. Vitamin D deficiency accelerates ageing and age-related diseases: a novel hypothesis. J Physiol. 2017;595(22):6825–6836.
   PubMed Web of Science ®Google Scholar
• Drechsler C, Verduijn M, Pilz S, et al. Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. NDT. 2011;26(3):1024‐32.
   Google Scholar
• Melamed ML, Thadhani RI. Vitamin D therapy in chronic kidney disease and end stage renal disease. Clin J Am Soc Nephrol. 2012;7(2):358‐65.
   Web of Science ®Google Scholar
• Christakos S, Dhawan P, Verstuyf A, et al. Vitamin D: metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev. 2016;96(1):365‐408.
   Web of Science ®Google Scholar
• da Silva Canhos MM, de Oliveira RC, Modelli de Andrade LG, et al. Martin Association between vitamin D levels and mortality in hemodialysis patients: a cohort study. Ren Fail. 2020;42(1):225–233.
   PubMed Web of Science ®Google Scholar
• Javanbakht MH, Mohammady H, Fooladsaz K, et al. Are Serum Levels of F2-Isoprostane and Oxidized-LDL Related to Vitamin D Status in Type 2 Diabetic Patients? A Case-Control Study. Rep Biochem Mol Biol. 2016;5(1):26‐32.
   Web of Science ®Google Scholar
• Damasiewicz MJ, Toussaint ND. Is nutritional vitamin D supplementation beneficial in dialysis patients? Clin J Am Soc Nephrol. 2015;10(4):544‐6.
   Web of Science ®Google Scholar
• Köken T, Serteser M, Kahraman A, et al. Oxidative stress markers in hepatitis C infected hemodialysis patients. J Nephrol. 2002;15(3):302‐07.
   Web of Science ®Google Scholar
• Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV co-infection. Hepatology. 2006;43(6):1317‐25. .
   Web of Science ®Google Scholar
• Sezer S, Tutal E, Aldemir D, et al. Hepatitis C infection in hemodialysis patients: protective against oxidative stress? Transplant Proc. 2006;38(2):406‐10. .
   Web of Science ®Google Scholar
• Horoz M, Bolukbas C, Bolukbas FF, et al. Oxidative stress in hepatitis C infected end-stage renal disease subjects. BMC Infect Dis. 2006;6:114.
   PubMed Web of Science ®Google Scholar
• Kadiiska MB, Gladen BC, Baird DD, et al. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med. 2005;38(6):698‐710. .
   Web of Science ®Google Scholar
• Handelman GJ. Evaluation of oxidant stress in dialysis patients. Blood Purif. 2000;18:343–349.
   PubMed Web of Science ®Google Scholar
• Ho E, Karimi Galougahi K, Liu CC, et al. Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox Biol. 2013;1(1):483‐91.
   Web of Science ®Google Scholar
• Sunman H, Özkan A, Yorgun H, et al. Vitamin D levels predict the response to cardiac resynchronization therapy in patients with systolic heart failure. Turk Kardiyol Dern Ars. 2016;44:670–676.
   Web of Science ®Google Scholar
• Masiá M, Padilla S, Fernández M, et al. Oxidative Stress Predicts All-Cause Mortality in HIV-Infected Patients. PLoS One. 2016;11(4):e0153456. .
   Web of Science ®Google Scholar
• Bansal B, Bansal S, Mithal A, et al. D deficiency in hemodialysis patients. Indian J Endocrinol Metab. 2012;16(2):270–273.
   Google Scholar
• El Din US, Fayed A, El Nokeety MM, et al., Vascular Calcification Group. Vitamin-D deficiency is encountered in almost all egyptian stage 3-5 chronic kidney disease patients in spite of the sunny weather. Saudi J Kidney Dis Transpl. 2019;30(6):1389–1397. .
   Web of Science ®Google Scholar
• El-Arbagy AR, El-Zorkany KM, Helwa MA, et al. Assessment of vitamin D in hemodialysis patients. Menoufia Med J. 2020;33:122–126.
   Google Scholar
• Handelman GJ, Walter MF, Adhikarla R, et al. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int. 2001;59(5):1960–1966. .
   PubMed Web of Science ®Google Scholar
• Kim KM, Jung BH, Paeng KJ, et al. Alteration of plasma total F2-isoprostanes before and after hemodialysis in end-stage renal disease patients. Prostaglandins Leukot Essent Fatty Acids. 2004;70(5):475–478.
   Web of Science ®Google Scholar
• Lim PS, Chang YM, Thien LM, et al. 8-iso-prostaglandin F2alpha as a useful clinical biomarker of oxidative stress in ESRD patients. Blood Purif. 2002;20(6):537–542. .
   Web of Science ®Google Scholar
• Stępniewska J, Gołembiewska E, Dołęgowska B, et al. Oxidative stress and antioxidative enzyme activities in chronic kidney disease and different types of renal replacement therapy. Curr Protein Pept Sci. 2015;16(3):243‐48.
   Web of Science ®Google Scholar
• Makariou SE, Elisaf M, Challa A, et al. No effect of vitamin D supplementation on cardiovascular risk factors in subjects with metabolic syndrome: a pilot randomised study. Arch Med Sci Atheroscler Dis. 2017;2:52–60.
   Google Scholar
• Elgharably A, Gomaa AI, Crossey MM, et al. Hepatitis C in Egypt - past, present, and future. Int J Gen Med. 2016;10:1–6.
   PubMed Web of Science ®Google Scholar
• Kerollos KM, El-Ameen HA, El Wahed LA, et al. Prevalence and seroconversion of hepatitis C among hemodialysis patients in Assiut governorate. Egypt J Intern Med. 2020;32:2.
   Google Scholar
• Nascimento MM, Suliman ME, Bruchfeld A, et al. The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients. NDT. 2004;19(12):3112‐6.
   Google Scholar
• Kato A, Odamaki M, Nakamura H, et al. Elevation of blood thioredoxin in hemodialysis patients with hepatitis C virus infection. Kidney Int. 2003;63(3):2262–2268.
   Google Scholar
• Ríos-Ocampo WA, Daemen T, Buist-Homan M, et al. Hepatitis C virus core or NS3/4A protein expression preconditions hepatocytes against oxidative stress and endoplasmic reticulum stress. Redox Rep. 2019 Dec;24(1):17–26.
   PubMed Web of Science ®Google Scholar
• Reilly MP, Praticò D, Delanty N, et al. Increased formation of distinct F2 isoprostanes in hypercholesterolemia. Circulation. 1998;98(25):2822‐8. .
   Web of Science ®Google Scholar
• Davi G, Alessandrini P, Mezzetti A, et al. In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1997;17(11):3230‐5. .
   Web of Science ®Google Scholar
• Khadem Ansari MH, Omrani MD, Kheradmand F. Oxidative stress response in patients infected by diverse hepatitis C virus genotypes. Hepat Mon. 2015;15(2):e22069.
   Web of Science ®Google Scholar
• Da SNMO, Kalb AC, Vidales-Braz BM. et al. Oxidative stress: a comparison of different groups of patients with Hepatitis-C in hemodialysis units. Kidney Disord Clin Pract. 2015;12(1):104.
   Google Scholar
• Fabrizi F, Messa P, Martin P. Impact of hemodialysis therapy on hepatitis C virus infection: a deeper insight. Int J Artif Organs. 2009;32(1):1–11.
   Web of Science ®Google Scholar